Furthermore, given the observed immune‐enhancing effect, CNOT7 depletion could represent an effective adjuvant therapy in immunotherapy for HCC to prevent microbial infections and inflammation‐associated disease. The gene discussed is CNOT7; the disease is hepatocellular carcinoma.